Stephen Davis v. ExpicentRx, Inc.

CourtCourt of Chancery of Delaware
DecidedApril 28, 2026
Docket2025-0365-LM
StatusPublished

This text of Stephen Davis v. ExpicentRx, Inc. (Stephen Davis v. ExpicentRx, Inc.) is published on Counsel Stack Legal Research, covering Court of Chancery of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stephen Davis v. ExpicentRx, Inc., (Del. Ct. App. 2026).

Opinion

COURT OF CHANCERY OF THE STATE OF DELAWARE

LORI. W. WILL LEONARD L. WILLIAMS JUSTICE CENTER VICE CHANCELLOR 500 N. KING STREET, SUITE 11400 WILMINGTON, DELAWARE 19801-3734

April 28, 2026

Thomas P. Will, Esquire Thad J. Bracegirdle, Esquire Phillip Reytan, Esquire Justin C. Barrett, Esquire Morris, Nichols, Arsht & Tunnell LLP Bayard, P.A. 1201 North Market Street 600 North King Street, Suite 400 Wilmington, Delaware 19801 Wilmington, Delaware 19801

RE: Stephen Davis v. EpicentRx, Inc., C.A. No. 2024-0365-LM (LWW)

Dear Counsel,

This letter resolves defendant EpicentRx, Inc.’s exceptions to a Magistrate in

Chancery’s March 2, 2026 bench ruling on plaintiff Stephen Davis’s motions for

contempt and to appoint a receiver (the “Ruling”).1 In the Ruling, the Magistrate

appointed a limited-purpose receiver over EpicentRx to enforce the payment of

contempt sanctions and fees-on-fees arising from EpicentRx’s repeated violations of

a Fitracks advancement order.

The defendant takes exception to the Ruling, arguing that the appointment of

a receiver was unwarranted. I agree. Because EpicentRx cured the underlying

1 See Tr. of Rulings of the Ct. (Dkt. 92) (“Ruling”). C.A. No. 2024-0365-LM (LWW) April 28, 2026 Page 2 of 7

advancement arrearage before the Ruling, the coercive purpose of a receivership had

already been achieved. At that point, appointing a receiver was no longer necessary

to coerce compliance with the advancement order but functioned as a

disproportionate means to collect collateral penalties. The exceptions are therefore

granted, and the appointment of the receiver is vacated.

I. BACKGROUND

Davis is a former corporate secretary of EpicentRx.2 In April 2022, he was

named as a defendant in a California action.3 After EpicentRx refused to advance

his legal fees, Davis filed this action. In September 2024, Chancellor McCormick

granted summary judgment in Davis’s favor on his entitlement to advancement.4 A

Fitracks order was entered in December 2024.5 In April 2025, the case was

reassigned to Magistrate Mitchell.6

EpicentRx failed to satisfy its obligations under the Fitracks order. It cycled

through various excuses for its nonpayment, ranging from California wildfires to

insurance coverage disputes. The Magistrate held EpicentRx in contempt in

2 Verified Compl. for Advancement (Dkt. 1) ¶ 4. 3 Id. ¶ 18; see EpiRx, L.P. v. EpicentRx, Inc., 37-2022-00015228-CU-BT-CTL (Cal. Super. Apr. 25, 2022). 4 See Dkts. 26-27. 5 Dkt. 31. 6 Dkt. 32. C.A. No. 2024-0365-LM (LWW) April 28, 2026 Page 3 of 7

September 2025 and assessed a $5,000 fine.7 When EpicentRx continued to

withhold payment, the Magistrate issued a second contempt order in October 2025,

imposing over $45,000 of retroactive fines and escalating daily fines of $2,500.8

In December 2025 and January 2026, Davis filed his third and fourth motions

for contempt and requested the appointment of a receiver.9 On February 12, 2026—

one day before the original hearing date on those motions—EpicentRx wired Davis

nearly $270,000.10 This payment satisfied all undisputed fees and expenses incurred

in the underlying California action through December 15, 2025, plus interest and

fees-on-fees requested in Davis’s first demand under the Fitracks order.11 The

payment did not, however, cover approximately $425,000 in accrued daily fines, the

initial $5,000 sanction, or fees-on-fees incurred by Davis in litigating the contempt

motions.12

On March 2, 2026, the Magistrate issued the Ruling on Davis’s third and

fourth motions for contempt and to appoint a receiver, finding that EpicentRx

7 Dkt. 41. 8 Dkt. 48. 9 Dkts. 60, 63. 10 Dkts. 78-79. 11 Dkt. 79 at 2. 12 Dkt. 78 at 2. C.A. No. 2024-0365-LM (LWW) April 28, 2026 Page 4 of 7

remained in civil contempt.13 Noting the company’s “serial noncompliance” and

that monetary sanctions remained unpaid, the Magistrate appointed a limited-

purpose receiver to satisfy the unpaid sums.14

EpicentRx timely filed exceptions to the Ruling pursuant to Court of Chancery

Rule 144.15 On March 11, Chancellor McCormick reassigned this action to me for

the limited purpose of resolving the exceptions.16 The exceptions were fully briefed

as of April 2.17

II. ANALYSIS

Exceptions to a Magistrate’s final report are reviewed de novo.18 I have

reviewed the exceptions briefs, the Ruling, and other filings. A further hearing is

unnecessary; the dispute can be resolved on the papers.

Section 322 of the Delaware General Corporation Law authorizes the Court

of Chancery to appoint a receiver whenever a corporation “shall refuse, fail or

13 Ruling 43-44. 14 Id. at 42, 44. 15 Dkt. 82. 16 Dkt. 88. 17 See Def.’s Opening Br. in Supp. of Exceptions (Dkt. 93); Pl.’s Answering Br. in Opp’n to Def.’s Exceptions (Dkt. 96); Def.’s Reply Br. in Supp. of Exceptions (Dkt. 101). 18 See DiGiacobbe v. Sestak, 743 A.2d 180, 184 (Del. 1999); see also Ct. Ch. R. 144(b)(2). C.A. No. 2024-0365-LM (LWW) April 28, 2026 Page 5 of 7

neglect to obey any order or decree of any court of this State . . . .”19 EpicentRx

violated the court’s advancement and contempt orders. The statutory authority to

appoint a receiver is thus established.

But statutory authority does not mandate equitable execution. When crafting

a coercive sanction, this court is obligated to use the “least possible power adequate

to the end proposed.”20 The appointment of a receiver for a solvent, operating

company is an “extraordinary” and “drastic” remedy.21 It is to be imposed with

“scrupulous care” and is “not to be resorted to if milder measures will give the

plaintiff . . . adequate protection for his rights.”22

Here, the objective of the court’s contempt orders—securing compliance with

the advancement obligation—was achieved. EpicentRx belatedly advanced the

19 8 Del. C. § 322. TR Invs., LLC v. Genger, 2009 WL 4696062, at *18 n.74 (Del. Ch. Dec. 9, 2009) (citation 20

omitted). 21 See Gandhi-Kapoor v. Hone Cap. LLC, 305 A.3d 707, 722 (Del. Ch. 2023) (“Appointing a receiver for a solvent entity [] ‘is an extraordinary, a drastic and . . . an “heroic” remedy . . . .’” (quoting Maxwell v. Enter. Wall Paper Mfg. Co., 131 F.2d 400, 403 (3d Cir. 1942))). 22 Ross Hldg. & Mgmt. Co. v. Advance Realty Gp., LLC, 2010 WL 3448227, at *6 (Del. Ch. Sept. 2, 2010) (first quoting Salnita Corp. v. Walter Hldg. Corp., 168 A. 74, 76 (Del. Ch. 1933); and then quoting Maxwell, 131 F.2d at 403); see also Jagodzinski v. Silicon Valley Innovation Co., 2012 WL 593613, at *2 (Del. Ch. Feb. 14, 2012) (“The appointment of a receiver . . . is an ‘extraordinary remedy.’ Therefore, a court of equity will exercise the power to appoint a receiver cautiously and only as necessitated by the exigencies of the case before it.” (quoting Roth v. Laurus U.S. Fund, L.P., 2011 WL 808953, at *5 (Del. Ch. Feb. 25, 2011))). C.A. No. 2024-0365-LM (LWW) April 28, 2026 Page 6 of 7

principal amounts owed to Davis, bringing itself into compliance with the Fitracks

order. What remains unpaid are sanctions and fees-on-fees resulting from the

company’s contempt, which are collateral to Davis’s advancement right. Yet a

receiver was appointed to “cause [EpicentRx] to satisfy all amounts due to [Davis]”

and was granted “all powers generally available to a receiver,” including “full

Free access — add to your briefcase to read the full text and ask questions with AI

Related

DiGiacobbe v. Sestak
743 A.2d 180 (Supreme Court of Delaware, 1999)
Maxwell v. Enterprise Wall Paper Mfg. Co.
131 F.2d 400 (Third Circuit, 1942)
Salnita Corp. v. Walter Holding Corp.
168 A. 74 (Court of Chancery of Delaware, 1933)

Cite This Page — Counsel Stack

Bluebook (online)
Stephen Davis v. ExpicentRx, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/stephen-davis-v-expicentrx-inc-delch-2026.